Results 51 to 60 of about 4,983 (214)

Associated factors with discontinuation use of combined oral contraceptives [PDF]

, 2011
OBJETIVO: Avaliar as razões para descontinuar diversos anticoncepcionais orais combinados entre mulheres brasileiras iniciantes do método, residentes em áreas urbanas.
BAHAMONDES, Luis, BAHAMONDES, María Valeria, MELO, Nilson Roberto de, OLIVEIRA, Eliane, PINHO, Felipe   +4 more
core   +2 more sources

The Risk of Venous Thromboembolism Associated with Oral Contraceptive; the Search Is Still On

Archives of Academic Emergency Medicine, 2018
A few years after coming to the market, the first generation of oral contraceptive pills (OCPs) were linked to significant risk of venous thromboembolism (VTE). This increased risk was blamed on the presence of the estrogen-like compounds in these agents.
Ali Abdalvand
doaj   +1 more source

Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation

EMBO Molecular Medicine, 2021
Hormonal contraception exposes women to synthetic progesterone receptor (PR) agonists, progestins, and transiently increases breast cancer risk. How progesterone and progestins affect the breast epithelium is poorly understood because we lack adequate ...
Marie Shamseddin, Fabio De Martino, Céline Constantin, Valentina Scabia, Anne‐Sophie Lancelot, Csaba Laszlo, Ayyakkannu Ayyannan, Laura Battista, Wassim Raffoul, Marie‐Christine Gailloud‐Matthieu, Philipp Bucher, Maryse Fiche, Giovanna Ambrosini, George Sflomos, Cathrin Brisken   +14 more
doaj   +1 more source

Cardiovascular risk profile according to World Health Organization medical eligibility criteria for contraceptive use of women using hormonal contraception in Rio de Janeiro state, Brazil

International Journal of Gynecology &Obstetrics, Volume 172, Issue 3, Page 1675-1683, March 2026.
Abstract Objective Hormonal contraception, especially combined oral contraceptives, is associated with an increase in cardiovascular risk. Thus, we aimed to analyze the use of hormonal contraceptive methods in the state of Rio de Janeiro (Brazil), with a focus on determining whether contraceptive use follows the cardiovascular profile of women ...
Isabela Pereira Fonseca Brusth, Juliana Montani Raimundo, Helene Nara Henriques Blanc   +2 more
wiley   +1 more source

Effect of increased body weight and obesity on the incidence of gynecological pathology, during childbirth, postnatal period and the state of newborns [PDF]

Гинекология, 2016
Increased body weight and obesity affect the incidence of gynecological diseases, the development of children, the growth of estrogen-dependent diseases. The issues of prevention of obstetric complications in women with overweight and obesity through the
L Yu Karakhalis, M N Mogilina
doaj  

Experience of the use of drugs with thioctic acid in overweight women using combined oral contraceptives

Zaporožskij Medicinskij Žurnal, 2014
Introduction Overweight is a serious medical, social and economic problem of the modern society. Today it is established that the level of sexual activity in women is not dependent on the body mass index.
N. V. Avramenko, I. B. Gridina, O. A. Nikiforov, E. A. Lomeyko   +3 more
doaj   +1 more source

Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial

BMC Research Notes, 2023
Objective To evaluate if daily oral 75 µg of Desogestrel (DSG) for 3 months prior to the insertion of etonogestrel-releasing contraceptive implant (ENG-IMPLANT) might help reduce its premature discontinuation.
Valeria Lombardi Fäh, Rosa Catarino, Sarah Castillo, Maria Badda, Sibel Gezer-Dickschat, Friederike Thieringer, Sibil Tschudin, Manuela Viviano, Michal Yaron   +8 more
doaj   +1 more source

Formation of porous membranes for drug delivery systems [PDF]

, 1993
Highly crystalline porous hollow poly (-lactide) (PLLA) fibres suitable for the delivery of various drugs were obtained using a dry-wet spinning process.
Dijkstra, P.J., Eenink, M.J.D., Esselbrugge, H., Loman-Peters, A.M.P., Sam, A.P., Schakenraad, J.M., Witte, P. van de   +6 more
core   +3 more sources

NON-DEVELOPING PREGNANCY. THE ROLE OF HORMONAL CONTRACEPTION IN REHABILITATION TREATMENT

Акушерство, гинекология и репродукция, 2016
Non-developing pregnancy (NB) is main factor of reproductive losses. The stress developed after the NB like after the abortion which accompanied with excitation of the hypothalamic-pituitary system.
G. B. Dikke
doaj  

Hormonal contraception with desogestrel-induced medication use [PDF]

Гинекология, 2014
This article presents current information on existing methods hormonal contraception, covered medical and clinical aspects acceptability of hormonal contraceptives.An important emphasis is made on the benefits of Laktinet® in women of postpartum period ...
S A Levakov, N A Sheshukova
doaj